This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Paroxetine Prevents Migraines

Peter Hays

Published: January 15, 1997

Article Abstract

Letter to the Editor

Sir: There have been several reports indicating that serotoninselective reuptake inhibitors (SSRIs) can produce worthwhileimprovement in migraine treatment or prophylaxis. In particular,fluoxetine and fluvoxamine have been useful in prevention,and paroxetine has been effective in the treatment ofchronic daily headache.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 58

Quick Links: Neurologic and Neurocognitive , Neurology

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...